Gold firms on weaker dollar; palladium holds near record high

Gold prices held firm on Monday, supported by a weaker dollar ahead of the U.S. Federal Reserve’s meeting this week, while supply worries kept palladium near record highs hit in the previous session.

Spot gold was up 0.1% at $1,779.73 an ounce by 0931 GMT. U.S. gold futures rose 0.1% to $1,779.60.

“We have seen some short-term buying interest come back into the market in line with the weaker dollar and lower bond yields. But if we fail to break higher soon, then there is a risk we could run into some renewed period of profit taking,” said Saxo Bank analyst Ole Hansen.

“The main focus this week will be the FOMC (Federal Open Market Committee) meeting on Wednesday and what kind of signals that will be sent from there.”

Gold prices have not been able to move forward despite a weaker dollar and lower U.S. Treasury yields because of the metal’s failure to break above the psychological $1,800 barrier, analysts said.

The dollar slumped to an almost eight-week low against other major currencies on Monday.

Market participants are awaiting the Fed‘s two-day policy meeting starting on Tuesday, with the focus on the tapering of bond purchases.

Spot gold could retest resistance at $1,792 an ounce, having stabilised around a support at $1,772, said Reuters technical analyst Wang Tao.

Palladium rose 1.2% to $2,888.75 an ounce after a record peak of $2,925.14 on Friday.

“The (palladium) price is finding tailwind from the prospect of a renewed supply deficit,” Commerzbank analysts said in a note.

“This (higher price) is the result of robust demand from the automotive industry due to tougher emissions regulations for cars with combustion engines coupled with reduced supply.”

Silver rose 0.3% to $26.07 an ounce while platinum was up 0.5% at $1,236.

About Author

Related posts

Oxford Biomedica lifts outlook as AstraZeneca ramps up vaccine output

AstraZeneca (NASDAQ:AZN) UP 0.62% AT 7944 Oxford Biomedica on Tuesday doubled the revenue expectation from its COVID-19 vaccine supply deal with AstraZeneca (NASDAQ:AZN) after the drug maker commissioned more batches from the company in the second half of 2021. Shares of the cell therapy firm, which has an agreement...

Read More

Toyota Motor powers to record high with cyclical shares back in demand

Toyota Motor (NYSE:TM) UP 1.98% AT 8819 Shares of Toyota Motor (NYSE:TM) touched a record high on Tuesday as investors flocked back to automakers and other relatively cheap cyclical stocks while ditching tech companies that shone earlier in the pandemic. Toyota’s shares rose as much as 2.6% to 8,869...

Read More